180 related articles for article (PubMed ID: 10766165)
1. Inhibitor of apoptosis protein hILP undergoes caspase-mediated cleavage during T lymphocyte apoptosis.
Johnson DE; Gastman BR; Wieckowski E; Wang GQ; Amoscato A; Delach SM; Rabinowich H
Cancer Res; 2000 Apr; 60(7):1818-23. PubMed ID: 10766165
[TBL] [Abstract][Full Text] [Related]
2. Caspase-independent cell death induced by anti-CD2 or staurosporine in activated human peripheral T lymphocytes.
Déas O; Dumont C; MacFarlane M; Rouleau M; Hebib C; Harper F; Hirsch F; Charpentier B; Cohen GM; Senik A
J Immunol; 1998 Oct; 161(7):3375-83. PubMed ID: 9759854
[TBL] [Abstract][Full Text] [Related]
3. Functional characterization of Jurkat T cells rescued from CD95/Fas-induced apoptosis through the inhibition of caspases.
Ko SC; Johnson VL; Chow SC
Biochem Biophys Res Commun; 2000 Apr; 270(3):1009-15. PubMed ID: 10772942
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxicity of diacetoxyscirpenol is associated with apoptosis by activation of caspase-8 and interruption of cell cycle progression by down-regulation of cdk4 and cyclin B1 in human Jurkat T cells.
Jun DY; Kim JS; Park HS; Song WS; Bae YS; Kim YH
Toxicol Appl Pharmacol; 2007 Jul; 222(2):190-201. PubMed ID: 17559898
[TBL] [Abstract][Full Text] [Related]
5. Caspase-1 is not involved in CD95/Fas-induced apoptosis in Jurkat T cells.
Chow SC; Slee EA; MacFarlane M; Cohen GM
Exp Cell Res; 1999 Feb; 246(2):491-500. PubMed ID: 9925765
[TBL] [Abstract][Full Text] [Related]
6. Tumor-induced apoptosis of T cells: amplification by a mitochondrial cascade.
Gastman BR; Yin XM; Johnson DE; Wieckowski E; Wang GQ; Watkins SC; Rabinowich H
Cancer Res; 2000 Dec; 60(24):6811-7. PubMed ID: 11156370
[TBL] [Abstract][Full Text] [Related]
7. Study of caspase inhibitors for limiting death in mammalian cell culture.
Sauerwald TM; Oyler GA; Betenbaugh MJ
Biotechnol Bioeng; 2003 Feb; 81(3):329-40. PubMed ID: 12474256
[TBL] [Abstract][Full Text] [Related]
8. A caspase-independent pathway of MHC class II antigen-mediated apoptosis of human B lymphocytes.
Drénou B; Blancheteau V; Burgess DH; Fauchet R; Charron DJ; Mooney NA
J Immunol; 1999 Oct; 163(8):4115-24. PubMed ID: 10510346
[TBL] [Abstract][Full Text] [Related]
9. Caspase-mediated degradation of T-cell receptor zeta-chain.
Gastman BR; Johnson DE; Whiteside TL; Rabinowich H
Cancer Res; 1999 Apr; 59(7):1422-7. PubMed ID: 10197606
[TBL] [Abstract][Full Text] [Related]
10. Sequential two-step cleavage of the retinoblastoma protein by caspase-3/-7 during etoposide-induced apoptosis.
Fattman CL; Delach SM; Dou QP; Johnson DE
Oncogene; 2001 May; 20(23):2918-26. PubMed ID: 11420704
[TBL] [Abstract][Full Text] [Related]
11. Doxorubicin treatment activates a Z-VAD-sensitive caspase, which causes deltapsim loss, caspase-9 activity, and apoptosis in Jurkat cells.
Gamen S; Anel A; Pérez-Galán P; Lasierra P; Johnson D; Piñeiro A; Naval J
Exp Cell Res; 2000 Jul; 258(1):223-35. PubMed ID: 10912804
[TBL] [Abstract][Full Text] [Related]
12. Acceleration of apoptotic cell death after the cleavage of Bcl-XL protein by caspase-3-like proteases.
Fujita N; Nagahashi A; Nagashima K; Rokudai S; Tsuruo T
Oncogene; 1998 Sep; 17(10):1295-304. PubMed ID: 9771973
[TBL] [Abstract][Full Text] [Related]
13. p27KIP1 is down-regulated by two different mechanisms in human lymphoid cells undergoing apoptosis.
Frost V; Sinclair AJ
Oncogene; 2000 Jun; 19(27):3115-20. PubMed ID: 10871865
[TBL] [Abstract][Full Text] [Related]
14. Caspase inhibition in apoptotic T cells triggers necrotic cell death depending on the cell type and the proapoptotic stimulus.
Scheller C; Knöferle J; Ullrich A; Prottengeier J; Racek T; Sopper S; Jassoy C; Rethwilm A; Koutsilieri E
J Cell Biochem; 2006 Apr; 97(6):1350-61. PubMed ID: 16365881
[TBL] [Abstract][Full Text] [Related]
15. Helenalin triggers a CD95 death receptor-independent apoptosis that is not affected by overexpression of Bcl-x(L) or Bcl-2.
Dirsch VM; Stuppner H; Vollmar AM
Cancer Res; 2001 Aug; 61(15):5817-23. PubMed ID: 11479221
[TBL] [Abstract][Full Text] [Related]
16. Caspase-8/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis.
Engels IH; Stepczynska A; Stroh C; Lauber K; Berg C; Schwenzer R; Wajant H; Jänicke RU; Porter AG; Belka C; Gregor M; Schulze-Osthoff K; Wesselborg S
Oncogene; 2000 Sep; 19(40):4563-73. PubMed ID: 11030145
[TBL] [Abstract][Full Text] [Related]
17. Anti-apoptotic oncogenes prevent caspase-dependent and independent commitment for cell death.
Amarante-Mendes GP; Finucane DM; Martin SJ; Cotter TG; Salvesen GS; Green DR
Cell Death Differ; 1998 Apr; 5(4):298-306. PubMed ID: 10200475
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of caspase or FADD function blocks proliferation but not MAP kinase-activation and interleukin-2-production during primary stimulation of T cells.
Mack A; Häcker G
Eur J Immunol; 2002 Jul; 32(7):1986-92. PubMed ID: 12115619
[TBL] [Abstract][Full Text] [Related]
19. Cleavage of the calpain inhibitor, calpastatin, during apoptosis.
Pörn-Ares MI; Samali A; Orrenius S
Cell Death Differ; 1998 Dec; 5(12):1028-33. PubMed ID: 9894609
[TBL] [Abstract][Full Text] [Related]
20. Stromal derived factor-1 alpha (SDF-1 alpha) induces CD4+ T cell apoptosis via the functional up-regulation of the Fas (CD95)/Fas ligand (CD95L) pathway.
Colamussi ML; Secchiero P; Gonelli A; Marchisio M; Zauli G; Capitani S
J Leukoc Biol; 2001 Feb; 69(2):263-70. PubMed ID: 11272277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
